Liposomal amphotericin B therapy of murine histoplasmosis.
Liposomal amphotericin B (AmBisome) was compared with amphotericin B deoxycholate for the treatment of disseminated murine histoplasmosis. Liposomal amphotericin B was well tolerated and, milligram for milligram, was as potent as amphotericin B deoxycholate.
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1995
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162848/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7486941/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.8.1885 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|